170 related articles for article (PubMed ID: 36505407)
1. Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton's agammaglobulinemia.
Rise N; Touborg T; Lundsted DH; Dalager-Pedersen M; Mogensen TH
Front Immunol; 2022; 13():1057065. PubMed ID: 36505407
[TBL] [Abstract][Full Text] [Related]
2. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency.
Ponsford MJ; Shillitoe BMJ; Humphreys IR; Gennery AR; Jolles S
Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):525-534. PubMed ID: 34596095
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal Manifestations in X-linked Agammaglobulinemia.
Barmettler S; Otani IM; Minhas J; Abraham RS; Chang Y; Dorsey MJ; Ballas ZK; Bonilla FA; Ochs HD; Walter JE
J Clin Immunol; 2017 Apr; 37(3):287-294. PubMed ID: 28236219
[TBL] [Abstract][Full Text] [Related]
5. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature.
Devassikutty FM; Jain A; Edavazhippurath A; Joseph MC; Peedikayil MMT; Scaria V; Sandhya P; Govindaraj GM
Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):115-118. PubMed ID: 34495748
[No Abstract] [Full Text] [Related]
6. The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia.
Almontasheri A; Al-Husayni F; Alsuraihi AK; Binyahib H; Albanna AS
Am J Case Rep; 2021 Feb; 22():e929447. PubMed ID: 33612712
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection in a X-linked agammaglobulinemia adolescent: An immunological approach to treatment.
Stracuzzi M; Vanetti C; Clerici M; Zuccotti GV; Trabattoni D; Giacomet V
Pediatr Allergy Immunol; 2023 Mar; 34(3):e13921. PubMed ID: 36974650
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
Pereira NMD; Heath PT; Doerholt K; Almario-Hernandez AF; Gilmour C; Drysdale SB
Pediatr Infect Dis J; 2021 Dec; 40(12):e472-e474. PubMed ID: 34596628
[TBL] [Abstract][Full Text] [Related]
9. Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis.
Zhang YN; Gao YY; Yang SD; Cao BB; Zheng KL; Wei P; Chen LF; Chen WX
BMC Neurol; 2019 Dec; 19(1):320. PubMed ID: 31830942
[TBL] [Abstract][Full Text] [Related]
10. A rare genetic cause of bronchiectasis.
Botnaru V; Munteanu O; Cemîrtan S; Rusu D; Slevestru R
Pneumologia; 2016; 65(4):216-21. PubMed ID: 29542908
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of Bruton's agammaglobulinemia.
Stewart DM; Lian L; Nelson DL
Curr Allergy Asthma Rep; 2001 Nov; 1(6):558-65. PubMed ID: 11892085
[TBL] [Abstract][Full Text] [Related]
12. SARS-COV-2 infections in inborn errors of immunity: A single center study.
Cousins K; DeFelice N; Jeong S; Feng J; Lee ASE; Rotella K; Sanchez D; Jaber F; Agarwal S; Ho HE; Cunningham-Rundles C
Front Immunol; 2022; 13():1035571. PubMed ID: 36479106
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant.
Lindahl H; Klingström J; Da Silva Rodrigues R; Christ W; Chen P; Ljunggren HG; Buggert M; Aleman S; Smith CIE; Bergman P
J Clin Immunol; 2022 Aug; 42(6):1130-1136. PubMed ID: 35538387
[TBL] [Abstract][Full Text] [Related]
14. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia.
Conley ME; Howard V
J Pediatr; 2002 Oct; 141(4):566-71. PubMed ID: 12378199
[TBL] [Abstract][Full Text] [Related]
15. Possible COVID-19 reinfection in a patient with X-linked agammaglobulinaemia.
Loh SY; Bassett J; Hoodless EJ; Walshaw M
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33664039
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series.
Simard ML; Nadeau MA; Gauthier A; Cros G; Lavoie A
J Clin Immunol; 2023 Aug; 43(6):1067-1071. PubMed ID: 37093405
[No Abstract] [Full Text] [Related]
17. Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia.
Palomba E; Carrabba M; Zuglian G; Alagna L; Saltini P; Fortina V; Hu C; Bandera A; Fabio G; Gori A; Muscatello A
Int J Infect Dis; 2021 Sep; 110():338-340. PubMed ID: 34332085
[TBL] [Abstract][Full Text] [Related]
18. Gastric adenocarcinoma in the context of X-linked agammaglobulinemia: case report and review of the literature.
Staines Boone AT; Torres Martínez MG; López Herrera G; de Leija Portilla JO; Espinosa Padilla SE; Espinosa Rosales FJ; Lugo Reyes SO
J Clin Immunol; 2014 Feb; 34(2):134-7. PubMed ID: 24338562
[TBL] [Abstract][Full Text] [Related]
19. An X-linked agammaglobulinemia (XLA) patient with fever and disturbance of consciousness: infection with Torque teno virus?
Liu H; Zhao J; Yang L; Yang C; Liu Y
Int J Infect Dis; 2022 Feb; 115():26-29. PubMed ID: 34863924
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia.
Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N
Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
